Rua Bioscience reports record sales across key markets

Rua Bioscience (NZX:RUA) has reported record sales in New Zealand and Australia for March 2025, alongside continued strong demand in Germany. In New Zealand, March marked the company's highest-ever monthly sales, signaling both increased market share for Rua and overall expansion of the medicinal cannabis market. Australia also delivered a record month, with Rua achieving its highest-ever unit sales of key medicinal cannabis flower product lines, due to strengthened relationships with prescribers, distributors and patients. While demand in Germany remains robust, sales are temporarily constrained by supply shortages; the company anticipates resumption of growth as supply chain capacity is restored in the coming quarter. Rua Bioscience continues to focus on quality and accessible products, with new product launches planned for the coming months.